$3,26
▲ +$0,02
(+0,62%)
Vol 392K
Consenso de Wall Street
7 analistas · Dic 20252
Compra fuerte
4
Compra
1
Mantener
0
Venta
0
Venta fuerte
85,7%
Calificación de compra
Gráfico de Precio
Acciones similares
GALT
Galectin Therapeutics Inc
$268.2M
ACHV
Achieve Life Sciences Inc
$264.6M
SGMT
Sagimet Biosciences Inc
$183.5M
CNTB
Connect Biopharma Holdings Ltd
$157.6M
PRLD
Prelude Therapeutics Inc
$164.2M
ARTV
Artiva Biotherapeutics Inc
$105.3M
RNAC
Cartesian Therapeutics Inc
$187.5M
WHWK
Whitehawk Therapeutics Inc
$114.1M
NKTX
Nkarta Inc
$131.4M
Ganancias
Tasa de superación: 50,0%| Trimestre | EPS est. | EPS real | Sorpresa |
|---|---|---|---|
| Dic 2023 | $-19,13 | $-10,70 | +$8,43 |
| Sep 2023 | $-22,95 | $-41,25 | $-18,30 |
| Jun 2023 | $-61,20 | $-60,00 | +$1,20 |
| Mar 2023 | $-42,08 | $-86,25 | $-44,18 |
Ingresos y beneficios trimestrales
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Ingresos | — | — | — | — | — |
| Beneficio neto | -$3.8M | -$3.8M | -$2.5M | -$1.9M | -$2.1M |
Salud financiera
Flujo de caja libre
-$1.9M
Deuda neta
-$7.4M
Efectivo
$7.6M
Deuda total
$161K
A fecha de Sep 30, 2025
Comparación con pares
| Ticker | Cap. de mercado | P/E | P/S | ROE | Margen | Beta |
|---|---|---|---|---|---|---|
| CNTN | — | — | — | — | — | — |
| GALT | $268.2M | — | — | -258,6% | — | 1,03 |
| ACHV | $264.6M | — | 14,8 | -196,7% | -94,7% | 1,88 |
| SGMT | $183.5M | — | — | -42,4% | — | 2,75 |
| CNTB | $157.6M | — | 6,0 | -62,7% | -175,2% | -0,18 |
| PRLD | $164.2M | — | — | -51,0% | — | 0,98 |
| ARTV | $105.3M | — | — | -50,0% | — | 1,42 |
| RNAC | $187.5M | — | 97,3 | -3215,8% | -2489,8% | 0,49 |
Mayores tenedores
Top 5: 13,03%ARK Investment Management, …
6,31%
$10.3M
Clear Street Group Inc.
3,25%
$5.3M
Blackrock Inc.
1,49%
$2.4M
Vanguard Group Inc
1,14%
$1.9M
Feynman Point Asset Managem…
0,84%
$1.4M
A fecha de Dic 31, 2025
Últimas noticias
Sin noticias relacionadas aún